InvestSMART

Insights

Subscribe to our Free Insights Newsletter today

Going International with Gilead Sciences Inc.

Gilead Sciences Inc. (NASDAQ: GILD) is a large US biotech stock specialising in antiviral drugs to treat patients suffering from HIV, hepatitis C, influenza and other medical conditions. As the world's leading anti-viral company, Gilead holds strong market positions in some very lucrative markets. For investors the attraction of Gilead is its valuation, free cash-flow and potential growth opportunity.

01 Jul 2015
·
Article comments

Weaker iron ore prices to weigh on market

International markets appear to have found a level where they are happy to sit and wait on the next developments in the Greek debt crisis. Greece's failure to meet the deadline on its IMF payment looks to have been fully anticipated by markets. Barring unknowns, the next critical event for markets will be the outcome of Sunday's referendum.

01 Jul 2015
·
Article comments

Giving up on Azure

The clinical workflow company has issued another profit warning due to higher costs - but we have lost faith in the group.

29 Jun 2015
·
Article comments

Flight to quality

Initial market reactions to weekend news on Greece have understandably involved a flight to quality. This morning's early market reaction has included selling Eurodollars and stock futures on the one hand and buying $US; Japanese yen and gold on the other.

29 Jun 2015
·
Article comments

Greece and US interest rates remain the key focus

Markets seem to be exactly where they were last Friday as far as Greece is concerned. The world is waiting on another set of "last ditch" meetings with a general expectation that crisis will be averted but concerned that there is some room for doubt. The bottom line as far as today's trading is concerned may be to leave both buyers and sellers cautious.

26 Jun 2015
·
Article comments

4161 - 4176 of 97736 results

Page 261 of 6109